Anesthesia & Life Support

Edwards Lifesciences is a global cardiovascular medical device company headquartered in Irvine, California. The company designs, manufactures, and markets innovative technologies for treating cardiovascular disease, including transcatheter heart valves (aortic and mitral), surgical valve technologies, and implantable heart failure management systems. Product portfolio includes the SAPIEN transcatheter heart valve platform, PASCAL mitral and tricuspid technologies, surgical valve solutions, and PAP-guided therapy for heart failure management. Edwards operates in transcatheter valve replacement and repair, surgical heart valve replacement, and hemodynamic monitoring for critical care. The company serves hospitals, catheterization laboratories, and surgical centers worldwide. Edwards Lifesciences maintains FDA clearances and regulatory approvals across major markets. The company previously operated a Critical Care division focused on monitoring systems, which was divested to BD (Becton, Dickinson and Company). Edwards is recognized as a leader in minimally invasive cardiovascular interventions and structural heart disease management.

Dongguan Quanding Medical Supplies Co., Ltd. is an OEM/ODM manufacturer headquartered in Shenzhen (established 2008) specializing in medical electrode pads, surgical management consumables, and monitoring system accessories. The company manufactures and distributes across three primary product families: pain management electrodes (TENS pads), patient monitoring electrodes (ECG/EEG), and surgical/electrosurgical accessories (grounding pads, neutral electrodes, patient return pads). Product portfolio includes TENS replacement electrode pads for lower back and muscle pain relief, disposable ECG electrodes in multiple sizes and substrate materials (foam, non-woven fabric), electrosurgical grounding plates and pads for adult and infant use, and medical lead connection wires for high-frequency surgery. The company reports 17+ years of R&D experience, 200+ product categories, and 500+ distribution partners with 99% customer satisfaction. Manufacturing capabilities include design, mold fabrication, sample confirmation, production, strict QC inspection, and after-sale service. Certifications include ISO 9001, ISO 14001, ISO 18001, CE, and API standards. Primary markets are OEM/ODM partners and medical device distributors. No FDA 510(k) clearance mentioned on site.

Forj Medical is a global contract design and manufacturing organization (CDMO) specializing in advanced medical device development and high-volume manufacturing. The company operates 450,000+ square feet of manufacturing space across six global facilities (U.S., Costa Rica, Singapore, Indonesia) and assembles 250+ million devices and components annually. Core competencies include electromagnetic sensors and navigation systems, surgical energy systems, fluid and gas management solutions, optical systems, stimulation and active wearables, and consumables and components. Forj Medical provides end-to-end services from concept and full medical device system development through commercialization, including custom electromechanical system design, design for manufacturing (DFM), design for automation and scale, custom prototyping, and process and test development. Manufacturing capabilities are vertically integrated, encompassing PCBA manufacturing, precision molding, cable assembly, cleanroom operations, polymer and metal 3D printing, and automation. The company maintains ISO 13485 certification and holds five FDA Establishment Registrations. Quality management systems include robust QMS, traceability protocols, risk management, and audit readiness. Supply chain and operational services include supply chain management, service and maintenance, sustaining engineering, packaging and shipping, and international logistics. Clients span Fortune 500 medical device manufacturers and emerging medtech companies. The organization combines 4+ million combined hours of medical device engineering expertise across its portfolio.

Al.Chi.Mi.A. Srl is an Italian medical device manufacturer specializing in ophthalmic surgery products and human tissue banking solutions. The company develops and supplies a certified product line for anterior and posterior segment ophthalmic surgical procedures, designed for use in operating theaters. Their portfolio includes ophthalmic preservation and storage media, such as KERASAVE (a hypothermic storage medium containing amphotericin B for human donor cornea preservation), ophthalmic gases (GOT product line), and diagnostic ophthalmic solutions including OCIGEL. The company maintains an active R&D department focused on innovation in the ophthalmic field through screening and selection of raw materials, formulations, prototyping, and clinical validation of medical devices. Al.Chi.Mi.A. also operates in human tissue banking with certified processing solutions for human tissues and cells intended for transplantation. The company has published peer-reviewed research comparing their preservation media against established competitors and presents regularly at international medical meetings. Their products are designed to meet stringent quality and safety standards for ophthalmic surgical and tissue banking applications.

CONMED Corporation is a global medical technology company specializing in the design, manufacture, and distribution of surgical devices and patient care solutions. Founded in 1970, the company serves hospitals, ambulatory surgery centers, and physician offices worldwide with a comprehensive portfolio focused on orthopedic and general surgical specialties, plus patient monitoring systems. Core product lines include arthroscopy instruments, electrosurgical generators, insufflation systems (AirSeal®), surgical power tools, smoke evacuation systems, soft tissue implants (BioBrace®), suture anchors, and advanced surgical imaging systems. CONMED emphasizes clinical innovation and user experience, collaborating with medical professionals to deliver reliable solutions that enhance surgical outcomes and recovery while maintaining commitment to quality and customer-centric service.

Truer Medical is a U.S.-based medical device manufacturer specializing in precision-engineered disposables and accessories for anesthesia and perioperative care. Since 2007, the company has supplied hospitals, clinics, and surgery centers with temperature management disposables, airway management solutions (intubation stylets, esophageal stethoscopes), gas sampling lines, and tubing circuits. All products are ISO 13485 certified and CE marked. Truer Medical offers in-house contract manufacturing, design and product development, and FDA regulatory expertise. The company provides competitive pricing, same-day shipping, flexible MOQs, and private labeling options. Recently expanded into the veterinary medical device market.

Apical Instruments is a medical device design, engineering, and manufacturing company specializing in electrosurgical generators and related medical RF systems. Based in Redwood City, California, Apical provides end-to-end product development services including proof-of-concept evaluation, prototype development, design validation, and full-scale manufacturing. The company maintains ISO 13485 Design Control processes and FDA Quality System compliance, with expertise in regulatory submissions (FDA 510(k), European notified body audits) and medical device patents. Apical serves biotechnology and medical device firms seeking to streamline development timelines while ensuring quality and regulatory compliance from inception through production and ongoing support.

Med Storm Innovation AS develops the PainSensor, an objective nociception monitoring device designed for perioperative anesthesia management and pain assessment. The PainSensor measures skin conductance algesimetry (SCA) to quantify nociceptive response in real time, providing indices for pain perception, awakening depth in unconscious patients, nerve block efficacy, and withdrawal symptoms. The device is based on skin sympathetic nerve activity and acetylcholine signaling, operating independently of temperature, neuromuscular blockers, alpha-2 agonists, epinephrine, beta-blockers, hypoxia, blood volume changes, and perioperative anxiety in conscious patients. Clinical validation spans over 80 peer-reviewed studies demonstrating rapid index response (within seconds) with low inter-individual variation. The PainSensor software integrates with existing multiparameter monitors from Philips and Masimo; Mindray and Draeger integration are in development. The company has received CE Mark (MDR 2017/745 Class IIa), ISO 13485 certification, and has an FDA approval pathway underway. Med Storm has received recognition including Eurostars grants (top 10% of applications), the Society for Technology in Anesthesia award for clinical utility, and Innovation Norway entrepreneur and AstraZeneca pain research prizes. The technology addresses the significant clinical need for objective, quantitative pain monitoring to optimize anesthesia dosing and reduce opioid-related complications.

Stellartech Research Corporation is an ISO 13485:2016-registered contract manufacturer and product development partner specializing in sophisticated medical devices utilizing radiofrequency, ultrasound, and other energy-delivery sources. The company designs and manufactures complex medical systems that typically combine disposable patient-contact devices with microprocessor-controlled instruments featuring advanced electronics for sensor feedback and controlled therapeutic energy delivery. Core competencies include catheter-based systems (including balloon electrode catheters), surgical probes, diagnostic instruments, and minimally invasive therapy devices. Stellartech operates a 68,000 sq. ft. facility capable of manufacturing Class II and Class III devices under FDA QSR compliance and ISO 13485:2016 quality management systems. Beyond contract manufacturing, the company provides full-spectrum product development services—from concept and proof-of-principle through clinical evaluation, regulatory approval, and market introduction. Stellartech partners with device companies of all sizes, medical entrepreneurs, physicians, and investment groups, offering incubation services for new medical device enterprises using its manufacturing infrastructure and regulatory expertise. The company brings integrated capabilities in RF and ultrasound energy systems, complex electronics design, catheter technology, and regulatory pathway management, positioning it as a strategic partner for medical device innovators seeking to navigate the product development lifecycle.

Solo-Dex manufactures the patented Fascile® Continuous Peripheral Nerve Block (cPNB) catheter system for acute pain management in pre-, peri-, and post-surgical settings. The over-the-needle technology enables single-operator placement in approximately 5 minutes, eliminating the need for complex manipulation or sterile drapes. The MRI-compatible, single-use sterile kit includes a modified Touhy-tipped needle, fenestrated memory-curve catheter, luer connectors, filters, and securement devices. Clinical benefits include avoidance of general anesthesia risks, reduced opioid dependency, accelerated surgical recovery and discharge, decreased infection exposure, and improved patient satisfaction. FDA-cleared (K151072), CE-marked, and designed by anesthesiologists for anesthesiologists, the Fascile® catheter has treated over 7,000 patients and allows continuous medication modulation for multi-day pain-free recovery.

Terumo Aortic is a global medical device manufacturer based in Glasgow, Scotland, specializing in advanced solutions for aortic and peripheral vascular diseases. Formed in 2018 through the merger of Bolton Medical and Vascutek Ltd (both part of Terumo Corporation), the company develops and manufactures innovative endovascular and surgical devices for complex aortic pathology management. Their product portfolio includes vascular grafts, stent-grafts, fenestrated endovascular aortic repair (FEVAR) systems, intrasaccular aneurysm devices, and the TREO system. Terumo Aortic's offerings support both open-heart and minimally invasive surgical procedures, serving cardiac surgery centers and interventional vascular units globally. The company is committed to expanding treatment options and improving patient outcomes for those with complex aortic conditions through surgeon-led innovation and regulatory-compliant device development.

Laser Engineering designs, manufactures, sells, and services CO2 laser systems and accessories for multi-specialty surgical applications. The company specializes in sealed-tube CO2 laser technology, with over 30 years of industry experience. Their flagship Ultra MD CO2 Laser System is engineered for precision and reliability in neuro/spine, ENT, gynecology, urology, general, and plastic surgery disciplines. The sealed-tube design eliminates the need for external gas tank storage, reducing operational costs and complexity. Laser Engineering also manufactures the UltraLase CO2 Waveguide fiber line with HeNe aiming beams for enhanced surgical cutting precision at higher wattages. Complete accessory offerings include handpieces, micromanipulators, and sterilization-compatible components. The company provides comprehensive product support, training, and service capabilities to surgical facilities nationwide, emphasizing U.S. manufacturing and user-friendly interface design.

Carnegie Surgical LLC manufactures and distributes specialty surgical instruments for general surgery, plastic surgery, ENT, anesthesia, and oral-maxillofacial applications. The company specializes in high-quality stainless steel instruments including laryngoscopes, retractors, haemostatic forceps, curettes, uterine dilators, catheter guides, and hand surgery sets. They also supply sterile processing equipment such as wire baskets and mesh trays for instrument sterilization. Carnegie Surgical serves hospitals, surgical centers, and dental practices with both standard catalog items and custom OEM solutions. Founded in 2005, the company emphasizes continuous improvement in product quality and competitive pricing, with a commitment to customer service and clinical standards.

Fotona LLC is a Slovenia-based manufacturer of advanced solid-state laser systems founded in 1964. The company specializes in energy-based medical and dental devices serving aesthetic dermatology, surgical, gynecological, and dental applications. With over 25,000 systems deployed across 100+ countries and 60,000+ customers globally, Fotona designs minimally invasive laser platforms featuring proprietary technologies including OPTOflex® articulated arms and Variable Square Pulse (VSP) technology. The company employs 276 staff and generates approximately $65.8 million in annual revenue. Core product lines include aesthetic lasers (skin resurfacing, hair removal, tattoo removal, vascular lesion treatment), surgical lasers (lipolysis, hyperhidrosis, endovascular treatment), dental lasers (hard/soft tissue procedures, periodontics, implantology), and gynecology lasers (intimate health applications). Fotona emphasizes research and development, holds 300+ patents, and provides comprehensive global support through 80+ distributors plus the Laser & Health Academy for professional training and clinical education.

Typenex Medical is a Chicago-based medical device and supply company founded in 2004, specializing in patient safety and blood management solutions for hospitals, clinics, and surgery centers. The company manufactures a comprehensive portfolio of medical devices and consumables including blood identification systems (Typenex Blood Bands, FinalCheck Recipient Safety System), blood collection and transfer devices, patient identification labels and bands, anesthesia and respiratory supplies, laboratory products, floor fluid management systems, pharmacy labeling solutions (ArmorRx alcohol-resistant labels), operating room accessories, labor and delivery supplies, postoperative care products, urology devices, and vein therapy laser systems. Additionally, Typenex offers viral testing collection supplies and histology/cytology products. With approximately 78 employees, the company serves healthcare facilities across North America and internationally, including agreements with Premier, Inc. and distribution in Germany, Italy, and South Africa. Typenex focuses on affordable, clinically-proven solutions that enhance both clinician workflows and patient outcomes.

ThermaSolutions LLC is a global leader in hyperthermic cancer treatment systems, headquartered in White Bear Lake, Minnesota. The company manufactures and distributes the ThermoChem HT series (HT-2000 and HT-2500) of integrated hyperthermic intraperitoneal chemotherapy (HIPEC) devices for adjunctive surgical oncology. These systems heat and circulate perfusate solutions to therapeutic temperatures (42–43°C) within the intraperitoneal cavity during cytoreductive surgery for peritoneal surface malignancies, including pseudomyxoma peritonei and ovarian cancer. ThermaSolutions also offers the HurriChem device line—FDA-approved (HurriChem Device Kit for laparoscopic irrigation) and CE-marked (HurriChem Nebulizer for pressurized intraperitoneal chemotherapy/PIPAC)—which aerosolizes fluids for delivery via minimally invasive ports during laparoscopic procedures. Additional product offerings include disposable HIPEC procedure kits, whole-body hyperthermia systems (HEATT, in partnership with Verthermia), isolated limb perfusion products, the SurgiChem Dual Injector Pump, thermal insulators, lasso tubing drains, and chemo waste management products. The company maintains FDA 510(k) clearance for select devices and CE marking for international markets. ThermaSolutions provides comprehensive training, clinical support, and educational resources through the HIPEC Program Support initiative and partnerships with oncology organizations. Founded in 1999, the company operates a US headquarters in White Bear Lake, MN, and an international office in Breda, The Netherlands, serving hospitals and surgical centers globally through a distributor network.

Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures. Founded in 1987 and headquartered in South Jordan, Utah, the company employs approximately 7,000 people worldwide and serves hospitals and physicians across the globe. Merit specializes in devices for cardiology, radiology, oncology, critical care, and endoscopy applications. The product portfolio includes catheters, guide wires, balloons, inflation devices, syringes, needles, stents, biopsy tools, drainage systems, embolics and delivery systems, access devices, and monitoring equipment. Merit serves multiple clinical specialties including interventional cardiology, interventional radiology, gastroenterology, critical care, electrophysiology, nephrology, pulmonology, breast surgery, and interventional oncology. The company offers procedural solutions for cardiac catheterization, dialysis access, biopsy procedures, embolotherapy, stricture management, spine interventions, and structural heart applications. Merit operates globally with manufacturing and distribution capabilities supporting complex interventional procedures. The company provides clinician education through Merit's Think Education program and maintains regulatory compliance appropriate for disposable medical devices in the United States and international markets.

Century HLM, LLC manufactures the Century Heart Lung Machine (HLM), a cardiopulmonary bypass system designed for cardiac surgery and extracorporeal circulation support. The system features a Stöckert-designed centrifugal pump with exceptional durability and reliability, housed in a heavy-duty, single-piece raceway construction made from industrial-grade materials in the USA. The platform supports third-party centrifugal pump compatibility and includes integrated roller pump capability for dual 1/4" tubing. The CPC (Century Perfusion Console) touchscreen interface provides intuitive operation requiring only one hour of training, with monitoring and control of four pressures, four temperatures, four timers, and four detectors (two bubble, two level), plus automatic cardioplegia functions. The system includes an industry-leading UPS battery backup providing 2 hours of full system power or 5 hours of arterial pump operation. Data logging captures parameters every 10 seconds (5 seconds during alarms) and can be downloaded via USB or streamed to EMR systems via RS-232. The console base accepts standalone centrifugal pumps, cardioplegia systems, and compact heater-coolers. The company emphasizes low total cost of ownership, backed by 24/7 technical support and a 4-year warranty. Customization options include LED lamp, laptop tray, writing tray, mast configurations, and storage shelves. The company is perfusionist-owned and perfusionist-driven in product design and support.

PAJUNK® GmbH is a family-owned German medical technology manufacturer founded in 1965, specializing in innovative devices for regional anesthesia, pain management, neurology, biopsy, and minimally invasive surgery. Based in Geisingen, Baden-Württemberg, the company operates manufacturing facilities in Germany and the USA with subsidiaries across Europe and North America. With approximately 700 employees, PAJUNK® exports its comprehensive portfolio to over 100 countries through approximately 150 distributors. The company's core product range includes atraumatic spinal needles (Sprotte®), peripheral nerve block needles (SonoPlex® II), peripheral catheter kits (Sonolong SoftSecure, E-Cath® II), cannulas, catheters, and specialized connectors (NRFit®). PAJUNK® emphasizes user-focused innovation, patient safety, advanced safety standards, and modern production techniques. The company continues to invest in product development and clinical education, celebrating 60 years of market leadership in regional anesthesia and minimally invasive surgical devices.

Blue Health International is a multi-service medical equipment provider operating across rental, distribution, and technical service channels. The company manages over 6,000 medical assets globally, serving more than 1,150 healthcare providers. Its core business units include: (1) Equipment Rental—offering new and pre-owned, multi-brand medical devices under Equipment-as-a-Service (EaaS) and traditional rental models with maintenance and SLA coverage for diagnostic imaging, life support, surgical equipment, and hospital furniture; (2) Distribution—exclusive and non-exclusive sales of new equipment, used units from internal stock, and consumables (reagents, needles, markers, contrast agents); and (3) Service—maintenance and remote monitoring solutions for MRI, CT, mammography, ultrasound, densitometry, and other diagnostic systems. The EaaS model emphasizes optimal capital allocation, outsourced equipment management, lower total cost of ownership, predictable cash flow, 24/7 technical support, and access to cutting-edge equipment lines. Blue Health maintains strategic partnerships with global manufacturers and emphasizes a 360° integration of technology, processes, and services. The company operates with a commitment to quality, sustainability, and supply chain responsibility, targeting healthcare providers seeking to optimize capital efficiency while maintaining high equipment availability and performance.

Surgyco LLC is a Puerto Rico-based medical consumables and equipment supplier founded in 2005. The company manufactures and distributes a comprehensive range of surgical and medical products to hospitals, government agencies, emergency clinics, doctor offices, and clinical laboratories across public and private sectors globally. Primary product lines include syringes and needles (FDA-approved, manufactured at high efficiency), bandages, gauzes, and wound care dressings. Surgyco also supplies anesthesia equipment, respiratory therapy products, personal protective equipment (PPE), medical-surgical products, procedure trays, and chest drainage systems and tubes. The company emphasizes safety, quality, and inventory availability with rapid order fulfillment capabilities. Manufacturing processes are FDA-approved and comply with regulatory standards. Surgyco positions itself as a quality-focused supplier with commitment to ethical business practices, customer-centric service delivery, and sustainable healthcare solutions. The company serves diverse healthcare settings from acute care to clinical diagnostics.

BrainSpace develops automated cerebrospinal fluid (CSF) management systems for acute care settings. The company's flagship product, the Intellidrop, automates external ventricular drainage (EVD) and lumbar drain management at the bedside, replacing labor-intensive manual monitoring with robotic precision and closed-loop automation. The Intellidrop features a wearable transducer that eliminates the need for manual leveling or zeroing, reducing nursing workload while improving patient experience and clinical outcomes. The system combines continuous sensing and gravity-based drainage principles trusted by neurosurgeons, enabling single-drop drainage control with personalized pressure or volume targets for each patient. The device generates high-frequency multimodal data that can be autonomously annotated in real-time, supporting research and AI training without manual data cleaning. BrainSpace's technology addresses CSF management for acute conditions including traumatic brain injury (TBI), hemorrhagic stroke, meningitis, post-neurosurgical care, and diagnostic evaluation for normal pressure hydrocephalus (NPH). The company targets ICU settings where improved automation is expected to support patient mobilization, reduce length of stay, alleviate nursing staffing challenges, and expand access to critical CSF management.

enableCV, LLC is an independent cardiac surgery device company focused on advancing minimally invasive and open-heart surgical procedures. The company develops innovative medical devices designed to provide continuous blood flow during cardiopulmonary bypass and enable next-generation cardiac surgery techniques. EnableCV's product portfolio includes the IntraClude intra-aortic occlusion device for minimally invasive cardiac procedures, the ProPlege peripheral retrograde cardioplegia device for coronary sinus occlusion and cardioplegia delivery, the QuickDraw Plus femoral venous cannula for blood drainage during bypass, and arterial cannulae (OptiSite and EZ Glide) for short-term perfusion. The company leverages deep expertise developed through its heritage with Edwards Lifesciences and collaborates with a preeminent medical advisory board to expand its portfolio. All devices are FDA-regulated and restricted to sale by or on the order of a physician. EnableCV serves cardiac surgeons and cardiothoracic surgical centers requiring specialized bypass and cardioplegia management solutions.

Caretaker Medical manufactures VitalStream ART, a dual-modality continuous hemodynamic monitoring platform for ICU, operating room, and high-acuity care settings. The device delivers beat-by-beat hemodynamic data through both invasive arterial line connectivity and non-invasive wearable sensors, enabling clinicians to monitor patients from pre-operative assessment through discharge. VitalStream operates as a unified platform compatible with standard arterial lines (no proprietary transducers required) and integrates with GE Carescape and Philips Intellivue monitors. The wearable sensor provides up to 10 days of continuous monitoring without cabling, supporting patient mobility across care phases. Clinical validation includes 20 peer-reviewed studies documenting accuracy in surgical, ICU, and critical care populations. The company reports deployment in 150+ clinical customers across 20+ hospitals. VitalStream is FDA-cleared and CE-marked. Key clinical benefits include early detection of hemodynamic decompensation (cardiac output decline, missed hypotensive events), reduced acute kidney injury and myocardial injury post-surgery, and cost savings up to $300k annually per ICU room versus competing invasive systems. Operational setup requires under 90 seconds with no complex configuration.

Covenant Healthcare Equipment and Consulting delivers cutting-edge surgical technologies designed to optimize operating room workflows, enhance surgical precision, and improve patient outcomes. The company specializes in advanced positioning systems, surgical smoke management, and anesthesia recovery solutions. Their core product portfolio includes TrenGuard (precision patient positioning system), Alesi Ultravision 2 (surgical smoke elimination and visualization), and ANEclear (anesthesia emergence management). These solutions address critical OR pain points: patient safety during positioning, surgeon visibility and occupational health during procedures, and faster, clearer patient emergence from anesthesia. Covenant positions itself as a provider of disruptive, technology-driven solutions that help healthcare systems build modern, efficient operating rooms. The company targets surgical facilities seeking to improve efficiency, reduce procedural complications, and advance clinical outcomes. While specific regulatory certifications are not detailed on the homepage, the focus on surgical precision, smoke management compliance, and anesthesia delivery suggests alignment with FDA and international standards for OR equipment. Covenant emphasizes consulting alongside equipment sales, indicating they provide implementation support and workflow optimization services.

Resolution Medical is a medical device development and manufacturing partner specializing in complex catheter delivery systems, active implantable devices, and component manufacturing. The company serves structural heart, cardiology, vascular, heart failure (VAD), neuromodulation, electrophysiology, and additional specialty markets including ENT, neurology, urology, oncology, endoscopy, and robotics. Core capabilities span the full product lifecycle: concept and design development, BioSimulation and testing with cardiovascular visualization in pressurized heart models, New Product Introduction (NPI) with design-for-manufacturing optimization, and end-to-end manufacturing from prototyping through commercial production. Resolution Medical operates specialized clean rooms, sterile packaging, labeling, and distribution infrastructure. In structural heart, the company develops implants and catheter delivery systems for mitral, tricuspid, aortic, and pulmonary valve interventions, as well as shunts, stents, closure devices, and embolic protection. Cardiology and vascular expertise includes complex delivery platforms, imaging and sensing catheter systems for peripheral, neurovascular, and cardiovascular applications, DVT/PE management, drug delivery, and flow management. Heart failure capabilities encompass VAD pump development, drivelines, and deployment systems. Neuromodulation focus includes Class III active implantables: implantable pulse generators (IPGs), leads, headers, adapters, and subassemblies for spinal cord stimulation, deep brain stimulation, vagus nerve stimulation, and peripheral nerve modulation. Electrophysiology specialization covers diagnostic mapping and energy delivery catheters with modalities including pulsed field ablation (PFA), RF energy, cryotherapy, and vapor therapy. The company maintains a quality management system per ISO 13485:2016 and operates under FDA guidelines. Resolution Medical was recently acquired by Resonetics (2025) and operates with 100+ engineers backed by 1,000+ combined years of experience.

Merlyn Medical is a family-owned distributor of premium medical devices founded in 1998, specializing in sterile single-use disposables and respiratory/airway management products. The company manufactures advanced endotracheal tubes, laryngeal masks, and post-operative support devices in FDA-, ISO-, and CE-compliant sterile environments. Core product lines include EndoTube™ (high-volume, low-pressure cuff endotracheal tubes), EndoMask™ (silicone laryngeal masks with rapid insertion design), and EndoFlex™ (flexible endotracheal tubes with innovative distal tips). Merlyn Medical serves operating rooms, endoscopy suites, surgery centers, and hospitals, with particular strength in anesthesia and airway management. The company emphasizes product reliability, consistent quality control, competitive pricing, and responsive customer service. Manufacturing meets rigorous medical-grade material standards and regulatory requirements. Distribution includes global reach with a history of patented innovations in airway management. Target markets include CRNAs, anesthesiologists, surgical nurses, and hospital procurement teams seeking cost-effective, dependable airway supplies backed by exceptional customer support.

Kairos Biosciences is a Salt Lake City, Utah–based regenerative medicine and surgical wound care company focused on enhancing acute surgical recovery. The company develops proprietary collagen and antimicrobial dressing technologies for high-risk surgical and wound environments. Primary product portfolio includes NuForra, a Type I collagen matrix powder featuring AngioReef™ technology with an 80–120 µm pore structure designed to support vascularization in complex surgical wounds, and PurForm AM, a silicone-backed antimicrobial foam dressing containing PHMB (Polyhexamethylene Biguanide) for post-operative wound management. Kairos targets community hospitals, long-term acute care hospitals (LTACHs), VA/DoD facilities, and specialized wound care centers. The company is DOBE-certified (Disabled Owned Business Enterprise), providing procurement advantages for distributor partners. Kairos emphasizes rapid innovation, proprietary formulation science, and patient-first product development with a lean organizational structure.

Codonics, Inc. is a Cleveland-based medical technology innovator specializing in patient safety and medication management solutions. Founded in 1982, the company has deployed over 60,000 installations across more than 110 countries. The Safe Label System (SLS)—Codonics' flagship product—enhances medication safety through real-time barcode scanning and automated labeling at the point of care, reducing administration errors and ensuring TJC and ISMP compliance. SLS integrates seamlessly with anesthesia drug carts and pharmacy workflows across operating rooms, intensive care units, patient floors, and pharmacy departments. Additional offerings include the SLS-Wave (hands-free scanning), Safe Waste System (controlled substance tracking), WasteLog (waste verification), and SLS Administration Tool (formulary management). Recognized as a Top 100 Healthcare Technology Company of 2024 and awarded Medication Safety Technology Company of the Year 2025, Codonics delivers solutions that streamline clinical workflows, improve charge capture, ensure 340B compliance, and prevent medication errors in perioperative and procedural settings.

3T Medical Systems, Inc. (founded 1998) is a US-based medical device distributor and manufacturer specializing in surgical support equipment and clinical consumables. The company serves anesthesiologists, operating room nurses, sterile processing staff, infection prevention specialists, and surgeons performing specialized surgical procedures. 3T Medical operates a large distribution facility in the Midwest and a sales office in the Mid-Atlantic region, serving both domestic and international healthcare markets. The company's primary product lines include blood management systems (CONSTAVAC™ CBCII System for intraoperative blood reinfusion), anesthesia and laryngoscopy equipment, regenerative medicine products, and precision temperature management systems (Altrix, acquired from Stryker in 2025). 3T Medical also acquired Enterix, Inc. in 2022, expanding its portfolio in regenerative medicine and wound care solutions. 3T Medical holds ISO 13485:2016 certification, demonstrating compliance with international medical device quality management standards. The company focuses on reducing healthcare costs while improving patient outcomes through specialized equipment designed for complex surgical environments and perioperative care. Products are distributed to hospitals, surgical centers, and clinical institutions requiring blood management, temperature control, and anesthesia support capabilities.

Life Recovery Systems manufactures the ThermoSuit®, a non-invasive rapid patient cooling system for therapeutic hypothermia induction in emergency and operating room settings. The ThermoSuit achieves target body temperature of 33°C in approximately 30 minutes using rapid thin liquid convection technology—faster than traditional cooling blankets and gel pads. The system is designed for acute care applications including ischemic stroke, cardiac arrest, and other emergency conditions where controlled therapeutic hypothermia may improve patient outcomes. The company has published peer-reviewed clinical data in Frontiers of Neurology (2025) demonstrating safety and feasibility in acute ischemic stroke patients under an FDA Investigational Device Exemption. Life Recovery Systems is actively advancing clinical evidence through randomized controlled trials in partnership with the FDA. The ThermoSuit represents a significant advancement in non-invasive temperature management technology for critical care environments, addressing the clinical need for rapid and precise patient cooling in time-sensitive emergency procedures.

Mevion Medical Systems is a radiation therapy company specializing in compact proton therapy systems for cancer treatment. Founded in 2004 and based in Littleton, Massachusetts, Mevion has raised $528.5 million in funding and maintains international offices in the United Kingdom and Japan. The company's flagship MEVION S250 Series comprises the MEVION S250 Proton Therapy System, MEVION S250i with advanced pencil beam scanning capabilities, and MEVION S250-FIT, designed for integration into existing radiation oncology departments. Mevion's systems are recognized for their compact design, which significantly reduces footprint, complexity, and capital/operating costs compared to conventional proton therapy equipment. The systems deliver 97–98% uptime and have achieved FDA clearance and CE marking. More NCI-Designated Cancer Centers select Mevion than any competing proton therapy vendor, reflecting strong clinical adoption and market leadership in particle therapy.

KelCor manufactures single-use, individually packaged airway and eye taping systems designed to eliminate cross-contamination and infection transmission risks associated with traditional multi-use tape rolls in anesthesia and perioperative settings. The KC Airway Taping System secures adult oral and nasal endotracheal tubes with a smart, efficient design that adapts to all standard airway devices. The KC Eye Tape applies and removes uni-directionally to preserve eye closure and minimize corneal injury risk during anesthesia. Both products address a critical patient safety gap by replacing contaminated reusable tape with clean, cost-effective single-patient-use alternatives. Designed by anesthesia practitioners, KelCor's taping solutions are constructed from familiar materials while elevating infection prevention standards in perioperative care.

Jiangsu Yongle Medical Technology Co., Ltd. is a professional manufacturer of anesthetic laryngoscopes and endoscopic visualization equipment with 19 years of production experience. Founded in 2014, the company specializes in video laryngoscopy systems, flexible fiber optic laryngoscopes, anesthesia pharyngeal laryngoscopes, and related airway management instruments. The company produces the SMT series medical visualization laryngoscopes used in anesthesia departments, emergency care, ICU, and pediatric settings for intubation, emergency ventilation, and difficult airway management. Products feature cold light source illumination (6000 Lux), full waterproof design (IPX7 rating), photo/video capabilities, and compatibility with both reusable and disposable blades. The company holds CE0197, FDA registration, and ISO 13485 certification, with products distributed nationally and internationally across America, Europe, South Africa, and Southeast Asia.

NeuroOne Medical Technologies develops minimally invasive diagnostic and therapeutic neurosurgical devices based on proprietary thin-film electrode technology. The company's primary platform enables high-definition neuronal recording and ablation for functional neurosurgery, with an initial focus on epilepsy and trigeminal neuralgia treatment. Core products include the OneRF® Radiofrequency Ablation System (FDA-cleared K231675 for functional neurosurgical procedures; K251243 for trigeminal nerve ablation), which uniquely performs both diagnostic mapping and therapeutic ablation using the same stereotactic electroencephalography (sEEG) electrode. The Evo® sEEG System (FDA-cleared K222404) provides temporary subsurface brain recording, monitoring, and stimulation, while the Evo® Cortical Electrodes (FDA-cleared K192764) offer surface brain recording with reduced immunological response and improved cable management. NeuroOne's flexible thin-film electrode platform is designed to provide higher-resolution neural signal acquisition compared to conventional rigid electrodes, potentially reducing infection risk and procedure complexity. The company is developing a comprehensive portfolio for neurological applications beyond epilepsy, working with leading neurosurgical centers including Mayo Clinic. All devices are subject to federal restriction to sale by or on the order of a physician.

IDMED develops and markets innovative medical devices for anesthesia and intensive care monitoring. The company specializes in automated pupillometry and neuromuscular transmission (NMT) monitoring solutions used globally in operating rooms and ICU settings. The NeuroLight® pupillometer provides accurate, automated measurement of pupil size and reactivity for neurological assessment and prognostication in intensive care environments. The ToFscan® is a quantitative neuromuscular blockade monitor utilizing three-dimensional sensors with a wide sensor range and requires no pre-use calibration. Both products are designed to enhance clinical decision-making and patient safety in perioperative and critical care settings. IDMED's focus on neurological and neuromuscular monitoring positions the company within the specialty diagnostic and patient monitoring equipment segment, serving anesthesiology, critical care, and neurology departments.

Verathon Inc. is a global medical device manufacturer specializing in airway management and bladder volume measurement solutions. Founded in 1984 and headquartered in Bothell, Washington, the company serves over 80 nations with a workforce of 360+ employees. As a subsidiary of Roper Technologies, Verathon is recognized for innovation in critical care and emergency medicine. The company's flagship GlideScope® video laryngoscope platform provides hyperangulated video-assisted intubation across single-use, reusable, and handheld configurations, addressing anesthesia, critical care, EMS, and pediatric airway management. The BladderScan® product line delivers noninvasive portable ultrasound systems for accurate post-void residual measurement and urinary retention management. BFlex® single-use bronchoscopes complement the total airway solution portfolio. Verathon emphasizes clinical evidence, sustainability (including bio-based plastic initiatives), and strong customer partnerships to enhance patient outcomes.

Spectrum Medical Inc is a global medical technology company specializing in cardiac perfusion and intensive care solutions for operating rooms and ICUs. Headquartered in Gloucester, United Kingdom, with significant US operations in Fort Mill, South Carolina, the company serves hospitals across more than 60 countries. The company develops and manufactures the Quantum Perfusion Technologies product line, including cardioplegia delivery systems and perfusion management solutions designed to improve clinical outcomes in cardiac surgery. Their Quantum Micro-Cardioplegia Delivery System received FDA 510(k) clearance. Spectrum Medical also offers Quantum Informatics-24, a health IT solution for cardiac and ICU environments. The company markets its solutions to cardiac surgeons, perfusionists, and ICU teams, combining hardware platforms with clinical decision support and data management capabilities. Products target high-acuity surgical and intensive care settings where cardiopulmonary perfusion and monitoring are critical. The company maintains regional sales and support offices in Europe, Italy, Australia/New Zealand, and the Middle East, with dedicated customer support and technical education resources available through their IFU (Instructions for Use) platform.

Senzime is a medical technology company founded in 1999 and headquartered in Uppsala, Sweden, specializing in advanced patient monitoring and diagnostic systems for anesthesia and acute care. The company's flagship product, TetraGraph, is an electromyography (EMG)-based neuromuscular blockade monitoring system that provides quantitative train-of-four (TOF) monitoring to optimize intubation conditions, neuromuscular block management, and reversal dosing during surgical anesthesia. TetraGraph has been used to monitor over one million patients worldwide and is trusted by thousands of clinicians. The system delivers real-time, objective measurements of neuromuscular function, enabling safer anesthesia practices, improved patient outcomes, and significant operational efficiencies including documented reductions in anesthesia drug spending. Senzime operates globally through direct sales offices in the US, Sweden, and Germany, supported by an extensive network of distributors across Europe, Asia-Pacific, and North America. Listed on NASDAQ Stockholm (ticker: SEZI), Senzime is committed to advancing the standard of care in perioperative monitoring through evidence-based solutions and comprehensive clinical support.

Artivion is a specialized cardiovascular medical device company focused exclusively on aortic and cardiac surgery solutions. The company manufactures and markets a comprehensive portfolio of devices for treating aortic diseases, aortic dissections, and cardiac valve disorders. Product lines include mechanical and biological heart valves (ON-X Aortic and Mitral Valves, CRYOVALVE allografts), aortic arch solutions (AMDS Hybrid Prosthesis, E-VITA OPEN NEO, NEXUS stent graft systems), thoracoabdominal and abdominal aortic stent grafts (E-TEGRA, E-LIAC, E-NSIDE TAAA), peripheral aortic devices, and ancillary surgical solutions including BIOGLUE surgical adhesive and decellularized pericardium (PHOTOFIX). Artivion recently acquired Ascyrus Medical in 2020, expanding its aortic arch offerings. The AMDS Hybrid Prosthesis, developed for acute DeBakey Type I aortic dissections, received FDA Humanitarian Device Exemption (HDE) in December 2024 and is supported by the PERSEVERE pivotal clinical trial. Products are regulated through FDA 510(k) clearances and PMA pathways, with multiple investigational device exemptions (IDEs) active. The company collaborates with cardiac and vascular surgeons worldwide and supports clinical evidence generation through real-world post-market studies and pivotal trials. Artivion serves hospitals, surgical centers, and cardiac/vascular surgery programs globally, with particular emphasis on advanced aortic interventions and valve replacement technologies.

HK Surgical is a leader in the development, distribution, and marketing of liposuction and fat harvesting/grafting surgical supplies, founded in 1998 by Dr. Jeffrey Klein. The company specializes in equipment and supplies for tumescent local anesthesia procedures, including the proprietary Klein Infiltration Pump (available in multiple models: KIP-II+, KTDD). HK Surgical offers a comprehensive product portfolio encompassing infiltration and aspiration pumps, surgical cannulas (reusable and single-use), fat collection and transfer systems, infiltration tubing sets, positioning pillows, super-absorbent surgical pads, OR table sheets, compression garments, and catheter sets. The company serves plastic surgeons, physicians, nurses, and patients, emphasizing superior quality, reliability, and value. Products are FDA-approved and designed for liposuction, body contouring, varicose vein ablation, and facial procedures. HK Surgical provides same-day shipping on orders placed by 1 PM PST and offers live customer support.

Med Surgical Instruments Inc. is a global provider of medical devices and surgical instruments serving healthcare providers in critical care, general surgery, regional anesthesia, urology, respiratory care, and cardiac care applications. The company manufactures and supplies a comprehensive range of surgical instrument sets and specialty medical devices for hospitals, surgical centers, and medical device manufacturers worldwide. Product lines include sterilization containers, general surgical instruments, orthopedic surgical sets, electrosurgical instruments, reconstructive and plastic surgery instruments, dental instruments, and veterinary surgery instruments. The company also offers custom graphic containers and Med-Cut scissors. Med Surgical operates an OEM division providing products and services to device manufacturers, and maintains repair and servicing capabilities including instrument reconditioning, warranty services, and additional technical support. The company serves markets across the USA, Europe, and Asia with availability varying by region. Quality control and instrument care protocols are documented, and the company is PayPal-verified for transactions.

OSYPKA is a multinational medical device manufacturer with over 45 years of experience specializing in interventional cardiology and pediatric cardiology solutions. The company develops and manufactures active implants and catheters for cardiac applications, including pacemaker electrodes and radiofrequency ablation systems. OSYPKA operates as both a branded product manufacturer and a contract development and manufacturing organization (CDMO) serving global medical device partners with turnkey solutions for implantable devices and catheters. The company pioneered the first fracture-resistant implantable pacemaker electrode and has developed innovative technologies in cardiac intervention and neurostimulation. OSYPKA maintains manufacturing and quality capabilities across three main locations: Germany (headquarters in Rheinfelden), the USA (Longmont, Colorado), and the Czech Republic (Odry). The organization holds ISO 13485:2016 certification, EU Quality Management System certification under MDR (Medical Device Regulation), and Czech Quality Management System certification. The company serves interventional cardiologists, hospital systems, and medical device OEMs worldwide with both proprietary product lines and custom manufacturing solutions.

Advanced Meditech International Inc., based in New York City since 1992, is a B2B supplier of surgical equipment and instruments designed to enhance safety, simplicity, and cost-effectiveness in medical practice. The company specializes in no-needle jet injection anesthesia devices (MadaJet systems), electrosurgery generators, thermal cautery equipment, ligating clips and appliers, sterilization and ultrasonic cleaning solutions, and PPE surgical masks. The MadaJet platform is available in multiple configurations for dental, general medical, urology, podiatry, and vasectomy applications, enabling local anesthesia delivery without needle injection. The company also distributes complementary surgical equipment from established manufacturers including Teleflex, Bovie, and Mada Medical. All products are rigorously tested and fully inspected before certification and shipment. Customer service is available 24/7 by phone, fax, and email.

Johnson & Johnson is a multinational healthcare company founded in 1886 in New Brunswick, New Jersey. It specializes in pharmaceuticals, medical devices, and consumer health products. The company operates primarily through two business divisions: Innovative Medicine and MedTech. Innovative Medicine develops therapies across oncology, immunology, neuroscience, and cardiopulmonary disease areas. MedTech innovates at the intersection of biology and technology, focusing on minimally invasive and personalized treatments in cardiovascular, orthopedic, surgical, and vision care. J&J's portfolio includes surgical supplies, antiseptic sutures, diagnostic devices, and therapeutic equipment. With over 260 subsidiaries and 130,000+ employees globally, J&J is one of the largest and most diversified healthcare organizations, committed to addressing complex health challenges through rigorous science and innovation.

MACB, LLC manufactures the MACB® Introducer, a surgeon-placed adductor canal block device designed for intraoperative regional analgesia in total knee arthroplasty (TKA) procedures. The device enables surgeons to deliver non-opioid pain management directly during surgery, providing 4–5 days of pain relief and facilitating same-day discharge for outpatient TKA in ambulatory surgery centers. The MACB® Introducer offers both catheter-based therapy and non-catheter options using liposomal bupivacaine, eliminating the need for additional anesthesia procedures and reducing opioid-related complications and hospital stays. Developed by Dr. Daniel Matthews, MD, FAAOS, an orthopedic surgeon with 30+ years of experience, the device has been extensively validated in clinical practice with over 2,100 placements and peer-reviewed publications demonstrating superior nerve coverage compared to ultrasound-guided blocks alone. The company distributes catheter-based therapy products exclusively through Avanos Medical Technologies in the United States. MACB targets orthopedic surgeons and surgical centers seeking to implement opioid-free pain management protocols for knee arthroplasty.

National Medical Products, Inc. (NMP) manufactures the J-Tip Needle-Free Injection System, an FDA-cleared medical device that delivers local anesthesia and medications using CO2-propelled jet injection technology. The single-use, sterile device administers buffered or preservative-free lidocaine subcutaneously without a needle, providing anesthetic effect within 1–2 minutes for IV insertion, blood draws, and routine needle procedures. Designed to minimize patient discomfort and address needle phobia across all ages, the J-Tip is used in emergency departments, pediatric care, and anesthesiology settings. Founded in 1989 and based in Irvine, California, NMP manufactures all products in the USA and serves over 400 partner hospitals, helping more than 5 million patients experience virtually pain-free procedures while enhancing patient satisfaction and operational efficiency.

Pramand LLC develops implantable medical devices using proprietary hydrogel technology to address unmet clinical needs across surgical interventions. The company focuses on creating hydrogel-based solutions that improve patient outcomes while reducing therapy costs. Pramand's portfolio includes three primary product lines: a hydrogel implant for minimizing intrauterine adhesions (IUAs) in gynecological procedures, a dural sealant for watertight dural closure following craniotomy in neurosurgery, and a hemostatic sealant patch for controlling moderate surgical bleeding. The company operates through a business model of self-funding preclinical development with financial partners supporting clinical development and commercialization. Pramand's leadership team has successfully launched over ten hydrogel-based medical device companies that have generated over $4 billion in value and exits, collectively serving over 5 million patients worldwide. The company's proprietary hydrogel platform positions it as a specialized developer in the implantable device sector, with particular expertise in surgical sealants and hemostatic applications.

Solo Pace Inc manufactures temporary pacing technology and systems engineered specifically for transcatheter heart valve (THV) procedures. The company specializes in precision pacing solutions that provide confident control during valve deployment while reducing patient risk. Product lines include the SoloPace CONTROL™ System, an innovative pacing platform designed to reduce pacing risk and improve procedural efficiency during THV interventions, and the SoloPace FUSION™ System, a fully integrated sterile kit that combines temporary intracardiac pacing with streamlined THV device delivery. These solutions address a critical clinical need in structural heart interventions where reliable, precise temporary pacing is essential during transcatheter aortic valve replacement (TAVR) and other valve procedures. The company serves interventional cardiologists, structural heart specialists, and cardiac catheterization laboratories. Solo Pace's products are designed for hospital-based cardiac catheterization and hybrid operating room environments. Specific regulatory certifications and manufacturing details are not provided on the available website content.

Founded in 1991, Adroit Medical Systems is an FDA-registered medical device manufacturer specializing in active and passive patient warming systems, localized hot and cold therapy equipment, and surgical drapes and instrument covers. The company manufactures Class I and Class II medical devices for clinical and veterinary applications, with products including hypo-hyperthermia water therapy systems (HTP-1500), forced-air convective warming units (Soft-Air OR-110), reflective heat blankets (ThermalX), cold therapy pads and wraps, and portable cooling systems (Mobile Ice). Adroit serves hospitals nationwide and veterinary clinics through major medical distributors including Medline, Cardinal Health, and Owens & Minor. ISO 13485:2003 and ISO 9001:2008 certified, the company manufactures all products in-house at its Tennessee facility and provides contract manufacturing services, equipment repair, and calibration support.

Oneg HaKarmel Medical Devices Ltd (OHK MED) is an Israeli medical device manufacturer founded in 1999, specializing in innovative solutions for critical care medicine, hemorrhagic shock management, and orthopedic/vascular surgical applications. The company develops and manufactures advanced physiological devices focused on blood loss management in limb surgery, severe hemorrhagic shock (SHS) resuscitation, and cardiac arrest emergency response. OHK MED's product platform combines strong regulatory compliance with strategic partnerships to address unmet clinical needs in emergency medicine and perioperative care.

Somavac Medical Solutions manufactures the SOMAVAC® Sustained Vacuum System (SVS), an FDA-cleared negative pressure wound therapy device designed for post-operative drain management following large flap-forming plastic and general surgeries. The system represents a significant advancement over traditional bulb-drain technology, offering closed-system fluid removal that enables patients to return to normal activities faster—clinical data shows drain removal approximately 30% sooner than conventional methods. The SOMAVAC® SVS is a wearable, fully enclosed system that continuously removes fluids while holding tissue layers together, eliminating the need for manual fluid stripping and bulb manipulation. Key differentiators include discretion, comfort, cleanliness, and mobility compared to legacy drainage approaches. The company operates a 24/7 call center for patient support and maintains FDA regulatory clearance for its indication. Patient testimonials highlight reduced recovery time, ease of self-management, and improved quality of life during post-operative healing. The device is positioned for use in acute post-surgical settings across plastic surgery, breast reconstruction, and general surgery applications. Somavac serves healthcare providers, nursing staff, and patients, with marketing and educational resources targeting all stakeholder groups.

Sedation Systems LLC manufactures the NITROUSEAL® system, a complete, FDA-cleared nitrous oxide sedation platform designed for safe, self-administered patient analgesia in medical and dental settings. The system features a patented disposable full-face mask and breathing circuit with state-of-the-art all-digital flowmeter technology, enabling precise nitrous/oxygen dosage control (0–50% nitrous, up to 70% in select regions). The NITROUSEAL® system is the only complete nitrous analgesia platform with integrated waste gas scavenging via the Miniscav® FDA-cleared gas evacuation system, minimizing occupational exposure to exhaled nitrous oxide and reducing room contamination—a key safety requirement endorsed by CDC, NIOSH, and OSHA. This opioid-free, rapid-onset sedation solution allows patients to drive themselves home post-procedure. Indicated for pediatric, obstetric, dental, urological, and facial/body procedural applications across hospitals and medical offices nationwide. The company provides comprehensive on-site training, clinical support, and uninterrupted service plans.

Boca Dental Regenerative is a comprehensive dental supplier offering a broad portfolio of equipment, instruments, consumables, and biomaterials for general dentistry, oral surgery, and regenerative procedures. Product lines include dental handpieces and electric motors, PRF (Platelet-Rich Fibrin) centrifuges and collection systems, bone graft materials (mineralized and demineralized allografts, bovine anorganic bone, pericardium membranes), dental instruments (curettes, luxators, elevators, extraction forceps, retractors, needle holders, scissors, scalpel handles), CBCT/3D imaging and digital impression scanners, dental chairs and stools, surgical lighting, sterilization cassettes (wire mesh and solid series), sutures (resorbable and non-resorbable), implant systems and guides, infection control supplies (gloves, surgical masks 510(k), PPE), blood handling consumables (collection tubes, butterfly needles, tube holders), and disposable sterile drapes. The company represents multiple brands including BocaDental Supply, Atomica, Fussen, and Prexion. They also offer PRF educational courses and certification training at multiple US locations (Boca Raton, New York, San Diego, Denver, Honolulu, Las Vegas, Los Angeles). The business model combines wholesale distribution with direct-to-practitioner sales via their e-commerce platform.

Pacific Hospital Supply Co., Ltd. (PAHSCO) is a Taiwan-based medical device manufacturer specializing in single-use and reusable medical consumables and drainage systems for critical care, surgical, anesthesia, and respiratory therapy applications. The company manufactures closed suction systems, pleural drain systems (both dry-seal and water-seal variants), closed wound drainage systems (evacuator bulb type), urinary drainage bags, and OHMEDA-branded medical gas outlets. PAHSCO serves hospitals and healthcare facilities globally with products designed for critical care wards, general surgical applications, wound drainage management, respiratory therapy and anesthesia support, pediatric/neonatal care, and medical gas system infrastructure. The company emphasizes R&D capabilities and quality manufacturing standards. Products are marketed across multiple specialty applications including critical care support, general surgery, equipment protective covers, and respiratory/anesthesia management. The company is listed as a public entity with investor relations and ESG (environmental, social, governance) commitments. All products appear to comply with international medical device standards for use in hospital and clinical settings.

Weihai Kaibo Medical Device Co., Ltd. is a Chinese medical device manufacturer founded in 2019, specializing in minimally invasive surgical instruments and endoscopic systems. Located in Weihai Medical Devices and Biopharmaceutical Industrial Park, the company is a national high-tech enterprise and member of the National Surgical Instruments Standardization Technical Committee. The company develops and manufactures innovative microinvasive surgical medical devices designed to work with endoscopic technology. Product portfolios span three major clinical areas: laparoscopic surgery, urological surgery, and gastrointestinal endoscopic diagnosis and treatment. The company holds 19 utility patent authorizations and participates in formulating national medical device standards. Recent product certifications include EU compliance certifications for disposable negative pressure drainage bags and suction connection tubing from German TÜV Rheinland.

SharpMed, LLC is a medical device development and commercialization partner based in Scottsdale, Arizona. The company specializes in bringing innovative medical device concepts from ideation through regulatory approval and commercial launch. SharpMed's core offering is comprehensive end-to-end support for medical device entrepreneurs and innovators, leveraging a multidisciplinary team with 150+ years of combined expertise in Class I and II device development. The company's service portfolio encompasses biomedical engineering, product design and prototyping, regulatory affairs, manufacturing guidance, clinical validation, legal affairs, M&A strategy, and go-to-market commercial planning. SharpMed's first commercial product is the Turbo® O₂ Cap, a Class I non-sterile airway accessory designed to deliver 100% oxygen directly to the glottic region during difficult or emergent intubations, helping prevent oxygen desaturation in paralyzed patients.

ANEclear is a patented medical device designed to accelerate the washout of inhaled volatile anesthetics from the brain at the end of surgery. The device uses the patient's own carbon dioxide to vasodilate cerebral vasculature and restore electrical signaling in neurons controlling wakefulness and breathing, enabling faster and safer anesthesia emergence. ANEclear is specifically indicated for elderly, obese, and pediatric patients at elevated risk for postoperative complications including delirium, postoperative cognitive dysfunction, airway obstruction, and nausea/vomiting. By rapidly reversing anesthetic effects in the brain, ANEclear reduces recovery time, lowers complications, and improves operating room and post-anesthesia care unit efficiency while reducing overall patient care costs.

McMurray Medical manufactures the McMurray Enhanced Airway (MEA), an innovative distal pharyngeal airway device designed to improve patient safety, clinician satisfaction, and healthcare cost outcomes. The MEA represents a significant redesign of traditional oral airways, which have remained largely unchanged for nearly 100 years. The device features a longer, softer, smaller-diameter construction with a shock-absorbing bite block that shifts bite pressure to the molars, reducing postoperative discomfort and dental damage risk. It integrates with anesthesia circuits and bag-valve-mask systems for delivery of apneic or passive oxygenation during intubation. The MEA addresses critical gaps in airway management by providing effective airway maintenance, relieving difficult mask ventilation, enabling secure placement without lubricant or tongue depressor, and reducing upper airway obstruction. The device is compatible with endoscopic procedures and supplied in individual pouches for convenient clinical use and stocking.

NovaMedUSA, Inc. is a manufacturer and distributor of specialty medical products serving anesthesiology, cardiology, neonatology, and critical care markets. The company specializes in temperature monitoring solutions, including core body temperature probes, neonatal skin temperature sensors compatible with major incubator systems (GE/Ohmeda, Dräger, Atom Medical), and wireless temperature monitoring. Product lines include fiber optic laryngoscopes (PREMIER, standard, LED, and MRI-conditional variants) for intubation procedures, esophageal stethoscopes (LIFESOUND) for heart/breath sound monitoring, and conductive patient warming systems (KOALA for adults and KOALA Infant Warmer for neonates) designed to prevent perioperative hypothermia. NovaMedUSA emphasizes energy-efficient, eco-friendly technology and SCIP-INF-10 compliant products. The company operates customer support Monday–Friday, 8:30 am–8:30 pm EST, with dedicated channels for current customers, prospective buyers, and dealer partners.